SCHEMBL16478048

SCHEMBL16478048

O=C1Nc2ccc(-n3nnc4ccccc43)cc2C1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 7/20 0.44
▸ MAOB P27338 7/20 0.44
▸ TNKS O95271 1/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ TGM2 P21980 5/20 0.41
▸ CES1 P23141 3/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ APAF1 O14727 1/20 0.40
▸ TDP2 O95551 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ SMAD3 P84022 1/20 0.40
▸ HKDC1 Q2TB90 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14217669 0.74 GABRA1 (0.60) LMNAHPGD
SCHEMBL12685491 0.74 RAB9A (0.47) TNKSRAB9ASMN1; SMN2NPC1KDM4E
SCHEMBL21312677 0.73 EGFR (0.59) TNKSRAB9ACES1NPC1ALDH1A1
SCHEMBL12204565 0.73 SMN1; SMN2 (0.62) TNKSRAB9ASMN1; SMN2NPC1KDM4E
SCHEMBL822777 0.72 SMN1; SMN2 (0.44) TNKSRAB9ASMN1; SMN2NPC1KDM4E
SCHEMBL12204569 0.71 RAB9A (0.56) RAB9ASMN1; SMN2NPC1KDM4EALDH1A1
SCHEMBL16230166 0.70 TNKS (0.37) TNKSRAB9ASMN1; SMN2NPC1KDM4E
SCHEMBL17355202 0.70 TNKS (0.37) TNKSRAB9ASMN1; SMN2NPC1KDM4E
SCHEMBL13589297 0.70 SMN1; SMN2 (0.52) TNKSRAB9ASMN1; SMN2NPC1KDM4E
SCHEMBL172700 0.69 ALDH1A1 (0.56) TNKSRAB9ASMN1; SMN2NPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2682393-A1 Inhibitors of HCV NS5A comprising a bicyclic core. Presidio Pharmaceuticals, Inc. (US) 2014-01-08 — — EP disclosed
Send feedback